ArticleClinical cardiology2025
Right Heart Contrast Echocardiography Microbubble Count and Migraine Severity: A Dose-Effect Relationship Study.
Article in Clinical cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveThis study aimed to investigate whether a dose-effect relationship exists between the number of microbubbles detected on right heart contrast echocardiography (RHCE) and the clinical severity of migraine.
methodsWe conducted a cross-sectional study of 190 adult patients diagnosed with migraine who underwent RHCE. Microbubble counts were categorized into four grades per frame (Grades 0-III) based on their appearance in the left atrium within three to six cardiac cycles after right atrial opacification. Migraine severity was assessed using the Migraine Disability Assessment (MIDAS) score and the Headache Impact Test (HIT-6). Multivariate linear regression was used to evaluate the association between microbubble grades and migraine severity. The predictive ability of the model was assessed using the residual plots and variance inflation factors. Sensitivity analyses were performed to test the robustness of the findings by adjusting for potential confounders.
resultsA clear dose-response relationship was identified, with patients in higher microbubble-grade groups demonstrating significantly elevated MIDAS and HIT-6 scores (p < 0.001). Patients with Grade III microbubbles reported the highest mean MIDAS (18.2 ± 6.1) and HIT-6 (64.8 ± 4.9) scores, compared to those in lower grades (p < 0.001). Regression analyses confirmed that the higher microbubble burden independently predicted migraine severity (β = 0.46, p < 0.001). Sensitivity analyses yielded consistent findings.
conclusionOur results suggest a notable dose-effect relationship between RHCE microbubble count and migraine severity. These findings highlight the potential role of right-to-left shunting as a physiological contributor to migraine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.